Related Experiment Video
Updated: Feb 5, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
[THE ROLE OF FIBROBLAST GROWTH FACTOR 21 (FGF21) IN THE REGULATION AND CORRECTION OF CARBOHYDRATE AND LIPID
Abstract:
Identification of the natural metabolic factors that are able to normalize insulin sensitivity and carbohydrate and lipid metabolism is necessary for the development of pharmacological approaches for the correction of obesity and Type II diabetes. Fibroblast growth factor 21 (FGF21) is an atypical member of the FGF family that functions as an endocrine hormone which regulates carbohydrate and lipid metabolism. It is involved in maintaining of energy homeostasis and adaptation to starvation and low temperature. In rodents, FGF21 administration increases energy expenditure, reduces body weight, fat mass, blood glucose and insulin levels, and improves insulin sensitivity. Pharmacologically, FGF21 is a promising new clinical candidate for the treatment of diabetes and obesity. This review highlights recent advances in our understanding ofmechanisms of FGF21's physiologic and pharmacologic anti-diabetic actions.
Insights
Fibroblast growth factor 21 (FGF21) is a key metabolic hormone that improves insulin sensitivity and carbohydrate/lipid metabolism. FGF21 shows promise as a therapeutic for obesity and Type II diabetes.
Area of Science:
- Endocrinology
- Metabolic research
- Pharmacology
Background:
- Obesity and Type II diabetes require novel therapeutic targets for metabolic regulation.
- Fibroblast growth factor 21 (FGF21) is an endocrine hormone regulating energy homeostasis.
- FGF21 plays a role in adaptation to starvation and low temperatures.
Purpose of the Study:
- To review the physiological and pharmacological mechanisms of FGF21's anti-diabetic actions.
- To highlight recent advances in understanding FGF21's role in metabolic health.
Main Methods:
- Literature review of studies on FGF21.
- Analysis of FGF21's effects on insulin sensitivity, carbohydrate, and lipid metabolism.
- Examination of FGF21's impact on energy expenditure and body weight in preclinical models.
Main Results:
- FGF21 administration in rodents improves insulin sensitivity and reduces blood glucose and insulin levels.
- FGF21 reduces body weight and fat mass by increasing energy expenditure.
- FGF21 is identified as a crucial factor in maintaining energy homeostasis.
Conclusions:
- FGF21 is a promising therapeutic candidate for treating obesity and Type II diabetes.
- Understanding FGF21's mechanisms is vital for developing new pharmacological strategies.
- FGF21 normalizes key metabolic parameters relevant to diabetes and obesity.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Power Factor Correction
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Regulation of Metabolism
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

